MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 150 filers reported holding MOMENTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,771,000 | +111.6% | 33,740 | +34.2% | 0.02% | +50.0% |
| Q2 2020 | $837,000 | +15.6% | 25,146 | -5.6% | 0.01% | 0.0% |
| Q1 2020 | $724,000 | -51.4% | 26,630 | -64.8% | 0.01% | -33.3% |
| Q4 2019 | $1,491,000 | -0.7% | 75,561 | -34.8% | 0.02% | 0.0% |
| Q3 2019 | $1,502,000 | -21.1% | 115,928 | -24.2% | 0.02% | -18.2% |
| Q2 2019 | $1,904,000 | -13.8% | 152,967 | +0.7% | 0.02% | -15.4% |
| Q1 2019 | $2,208,000 | +35.3% | 151,964 | +2.8% | 0.03% | +23.8% |
| Q4 2018 | $1,632,000 | -45.4% | 147,837 | +30.1% | 0.02% | -25.0% |
| Q3 2018 | $2,988,000 | +29.4% | 113,606 | +0.6% | 0.03% | +21.7% |
| Q2 2018 | $2,309,000 | +4.9% | 112,906 | -6.9% | 0.02% | +4.5% |
| Q1 2018 | $2,201,000 | +22.9% | 121,288 | -5.5% | 0.02% | +29.4% |
| Q4 2017 | $1,791,000 | +145.0% | 128,388 | +224.8% | 0.02% | +88.9% |
| Q3 2017 | $731,000 | +24.1% | 39,534 | +13.5% | 0.01% | +12.5% |
| Q2 2017 | $589,000 | +30.9% | 34,834 | +3.3% | 0.01% | +33.3% |
| Q1 2017 | $450,000 | -9.3% | 33,734 | +2.4% | 0.01% | -14.3% |
| Q4 2016 | $496,000 | +31.2% | 32,934 | +1.9% | 0.01% | +16.7% |
| Q3 2016 | $378,000 | +6.5% | 32,334 | -1.5% | 0.01% | +20.0% |
| Q2 2016 | $355,000 | +20.7% | 32,834 | +3.1% | 0.01% | +25.0% |
| Q1 2016 | $294,000 | -35.8% | 31,834 | +3.2% | 0.00% | -33.3% |
| Q4 2015 | $458,000 | -7.1% | 30,834 | +2.7% | 0.01% | -14.3% |
| Q3 2015 | $493,000 | +25.8% | 30,034 | -7.9% | 0.01% | +40.0% |
| Q4 2014 | $392,000 | +7.4% | 32,600 | +1.2% | 0.01% | 0.0% |
| Q3 2014 | $365,000 | -7.8% | 32,200 | -1.8% | 0.01% | 0.0% |
| Q2 2014 | $396,000 | +5.3% | 32,800 | +1.5% | 0.01% | 0.0% |
| Q1 2014 | $376,000 | -41.9% | 32,300 | -11.7% | 0.01% | -37.5% |
| Q4 2013 | $647,000 | +9.8% | 36,600 | -10.7% | 0.01% | 0.0% |
| Q3 2013 | $589,000 | -3.3% | 41,000 | +1.2% | 0.01% | 0.0% |
| Q2 2013 | $609,000 | +13.6% | 40,500 | +0.7% | 0.01% | 0.0% |
| Q1 2013 | $536,000 | – | 40,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |